John M. Climaco

Insider Reports History

Location
Park City, UT
Signature
/s/ Christopher Downs, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John M. Climaco:

Company Role Class Num Shares Value Price $ Report Date Ownership
Moleculin Biotech, Inc. Director Stock Options (right to buy) 165,169 12 Nov 2025 Direct
CNS Pharmaceuticals, Inc. Chief Executive Officer, Director Option to purchase common stock 9,761 17 Nov 2025 Direct

Insider Reports Filed by John M. Climaco

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CNSP CNS Pharmaceuticals, Inc. 17 Nov 2025 1 $0 4 Chief Executive Officer, Director 19 Nov 2025, 17:00
MBRX Moleculin Biotech, Inc. 12 Nov 2025 1 $0 4 Director 14 Nov 2025, 16:05
MBRX Moleculin Biotech, Inc. 04 Nov 2024 1 $0 4 Director 06 Nov 2024, 20:04
CNSP CNS Pharmaceuticals, Inc. 08 Apr 2024 2 $0 4 Chief Executive Officer, Director 10 Apr 2024, 21:50
CNSP CNS Pharmaceuticals, Inc. 01 Feb 2024 3 +$50,000 4 Chief Executive Officer, Director 06 Feb 2024, 10:27
CNSP CNS Pharmaceuticals, Inc. 16 Aug 2023 1 +$4,944 4 Chief Executive Officer, Director 16 Aug 2023, 16:01
MBRX Moleculin Biotech, Inc. 25 May 2023 1 $0 4 Director 26 May 2023, 17:16
CNSP CNS Pharmaceuticals, Inc. 28 Apr 2023 2 $0 4 Chief Executive Officer, Director 01 May 2023, 18:59
CNSP CNS Pharmaceuticals, Inc. 12 Apr 2023 1 +$10,408 4 Chief Executive Officer, Director 14 Apr 2023, 16:20
CNSP CNS Pharmaceuticals, Inc. 29 Mar 2023 1 $0 4 Chief Executive Officer, Director 31 Mar 2023, 19:28
MBRX Moleculin Biotech, Inc. 20 Jun 2022 2 $0 4 Director 22 Jun 2022, 19:04
CNSP CNS Pharmaceuticals, Inc. 28 Apr 2022 1 $0 4 Chief Executive Officer, Director 29 Apr 2022, 17:11
CNSP CNS Pharmaceuticals, Inc. 07 Mar 2022 1 +$9,835 4 Chief Executive Officer, Director 08 Mar 2022, 07:30
CNSP CNS Pharmaceuticals, Inc. 16 Nov 2021 1 +$6,400 4 Chief Executive Officer, Director 18 Nov 2021, 19:07
MBRX Moleculin Biotech, Inc. 07 Jun 2021 1 $0 4 Director 09 Jun 2021, 16:25